Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction.

作者: M. M. Walka , S. Däumling , H. -B. Hadorn , K. Kruse , B. H. Belohradsky

DOI: 10.1007/BF02072630

关键词:

摘要: We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The did respond 99 μg 1,25(OH)2D3 per day, but skeletal haematological abnormalities improved daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell normal values. At the age 7 years, he died from pneumonia. improvement calcium infusions 1.25(OH)2D3 suggests pathogenetic relationship hyperparathyroidism. Having antilipid IgM antibody titres up 1∶10.000 after Gram negative septicaemias, never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced 57%±3% age-matched controls (P<0.028). two pathological immune functions considered contribute well-known susceptibility infection rickets.

参考文章(15)
Uri A. Liberman, Charles Eil, Stephen J. Marx, Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II). Advances in Experimental Medicine and Biology. ,vol. 196, pp. 391- 406 ,(1986) , 10.1007/978-1-4684-5101-6_26
Paul G. Quie, Richard L. Simmons, Robert D. Nelson, Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. Journal of Immunology. ,vol. 115, pp. 1650- 1656 ,(1975)
Constantine D. Tsoukas, Stavros C. Manolagas, Diego M. Provvedini, Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Molecular and Cellular Endocrinology. ,vol. 43, pp. 113- 122 ,(1985) , 10.1016/0303-7207(85)90074-7
D.N. Kalu, Jacqueline Pennock, F.H. Doyle, G.V. Foster, Parathyroid hormone and experimental osteosclerosis. The Lancet. ,vol. 295, pp. 1363- 1366 ,(1970) , 10.1016/S0140-6736(70)91271-7
MICHAEL BLIZIOTES, ALFRED L. YERGEY, MARK S. NANES, JOSEPH MUENZER, MARTIN G. BEGLEY, NANCY E. VIEIRA, KANWAL K. KHER, MARIA LUISA BRANDI, STEPHEN J. MARX, Absent Intestinal Response to Calciferols in Hereditary Resistance to 1,25-Dihydroxyvitamin D: Documentation and Effective Therapy With High Dose Intravenous Calcium Infusions* The Journal of Clinical Endocrinology and Metabolism. ,vol. 66, pp. 294- 300 ,(1988) , 10.1210/JCEM-66-2-294
Sevgi Yetgin, Sinasi Ozsoylu, Myeloid metaplasia in vitamin D deficiency rickets. Scandinavian Journal of Haematology. ,vol. 28, pp. 180- 185 ,(2009) , 10.1111/J.1600-0609.1982.TB00512.X
G T Gamblin, U A Liberman, C Eil, R W Downs, D A DeGrange, S J Marx, Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts. Journal of Clinical Investigation. ,vol. 75, pp. 954- 960 ,(1985) , 10.1172/JCI111796
DonaldM Mccarthy, JillA Hibbin, JohnM Goldman, A role for 1,25-dihydroxyvitamin D3 in control of bone-marrow collagen deposition? The Lancet. ,vol. 323, pp. 78- 80 ,(1984) , 10.1016/S0140-6736(84)90007-2
Z. Bar-Shavit, D. Noff, S. Edelstein, M. Meyer, S. Shibolet, R. Goldman, 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcified Tissue International. ,vol. 33, pp. 673- 676 ,(1981) , 10.1007/BF02409507